We are excited to launch the journal *Contemporary Clinical Trials Communications*, an international peer reviewed open access sister journal of *Contemporary Clinical Trials*. It is a fruit of numerous discussions and surveys on a large number of trial practitioners and researchers to cover all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics.

*Contemporary Clinical Trials Communications* is unique in that it is outside the confines of disease specifications, it covers both randomized and non-randomized clinical trials and it strives to increase the transparency of medical research and reduce publication bias. By publishing scientifically valid original research findings irrespective of their perceived importance, significance or impact, the new journal strives to appeal to authorships and readerships from a wide range of disciplines including medicine, life science, pharmaceutical science, biostatistics, epidemiology, computer science, management science, behavioral science, and bioethics.

The editorial team of *Contemporary Clinical Trials Communications* comprises leading experts from a wide range of disciplines and from various regions, including Europe, North America, South America and Asia Pacific, where clinical trials have been frequently conducted. On behalf of the Editorial team, we welcome your submission of articles on clinical trials.

It is the ultimate goal of *Contemporary Clinical Trials Communications* to disseminate advances in clinical trials timely and to enhance the communication and collaboration within the global clinical trials community that ultimately benefits patients. We are looking forward to achieving the goal through close interactions among authors, reviewers, editorial members and readers.
